Circulation, Vol 84, 1136-1144, Copyright © 1991 by American Heart Association
AJ Moss, PJ Schwartz, RS Crampton, D Tzivoni, EH Locati, J MacCluer, WJ Hall, L Weitkamp, GM Vincent and A Garson Jr
BACKGROUND. The Long QT Syndrome (LQTS) is an infrequently occurring
familial disorder in which affected individuals have electrocardiographic
QT interval prolongation and a propensity to ventricular tachyarrhythmic
syncope and sudden death. We prospectively investigated the clinical
characteristics and the long-term course of 3,343 individuals from 328
families in which one or more members were identified as affected with LQTS
(QTc greater than 0.44 sec1/2). METHODS AND RESULTS. The first member of a
family to be identified with LQTS, the proband, was usually brought to
medical attention because of a syncopal episode during childhood or teenage
years. Probands (n = 328) were younger at first contact (age 21 +/- 15
years), more likely to be female (69%), and had a higher frequency of
preenrollment syncope or cardiac arrest with resuscitation (80%),
congenital deafness (7%), a resting heart rate less than 60 beats/min
(31%), QTc greater than or equal to 0.50 sec1/2 (52%), and a history of
ventricular tachyarrhythmia (47%) than other affected (n = 688) and
unaffected (n = 1,004) family members. Arrhythmogenic syncope often
occurred in association with acute physical, emotional, or auditory
arousal. The syncopal episodes were frequently misinterpreted as a seizure
disorder. By age 12 years, 50% of the probands had experienced at least one
syncopal episode or death. The rates of postenrollment syncope (one or more
episodes) and probable LQTS-related death (before age 50 years) for
probands (n = 235; average follow-up 54 months per patient) were 5.0% per
year and 0.9% per year, respectively; these event rates were considerably
higher than those observed among affected and unaffected family members.
CONCLUSIONS. Among 232 probands and 1,264 family members with prospective
follow-up, three factors made significant independent contributions to the
risk of subsequent syncope or probable LQTS-related death before age 50
years, whichever occurred first (Cox hazard ratio; 95% confidence limits):
1) QTc (1.052; 1.017, 1.088), 2) history of cardiac event (3.1; 1.3, 7.2),
and 3) heart rate (1.017; 1.004, 1.031). The findings from this prospective
longitudinal study highlight the clinical features, risk factors, and
course of LQTS.
ARTICLES
The long QT syndrome. Prospective longitudinal study of 328 families
Department of Medicine, University of Rochester School of Medicine and Dentistry, N.Y.
This article has been cited by other articles:
![]() |
N. Colman, A. Bakker, M. Linzer, J. B. Reitsma, W. Wieling, and A. A.M. Wilde Value of history-taking in syncope patients: in whom to suspect long QT syndrome? Europace, July 1, 2009; 11(7): 937 - 943. [Abstract] [Full Text] [PDF] |
||||
![]() |
R M Campbell, S Berger, and J Drezner Sudden cardiac arrest in children and young athletes: the importance of a detailed personal and family history in the pre-participation evaluation Br. J. Sports Med., May 1, 2009; 43(5): 336 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Iniesta, R. Yotti, and A. Garcia-Pastor Transient loss of consciousness with convulsions in two young adults with potentially fatal underlying heart disease: syncope versus seizures BMJ Case Reports, March 20, 2009; 2009(mar19_1): bcr0620080285 - bcr0620080285. [Abstract] [Full Text] |
||||
![]() |
S. S. Chugh, K. Reinier, T. Singh, A. Uy-Evanado, C. Socoteanu, D. Peters, R. Mariani, K. Gunson, and J. Jui Determinants of Prolonged QT Interval and Their Contribution to Sudden Death Risk in Coronary Artery Disease: The Oregon Sudden Unexpected Death Study Circulation, February 10, 2009; 119(5): 663 - 670. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss and I. Goldenberg Importance of Knowing the Genotype and the Specific Mutation When Managing Patients With Long-QT Syndrome Circ Arrhythmia Electrophysiol, August 1, 2008; 1(3): 219 - 226. [Full Text] [PDF] |
||||
![]() |
I. Goldenberg and A. J. Moss Long QT syndrome. J. Am. Coll. Cardiol., June 17, 2008; 51(24): 2291 - 2300. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Marijon, N. Combes, J. P. Albenque, J. R. Kapoor, and D. M. Roden Long-QT syndrome. N. Engl. J. Med., May 1, 2008; 358(18): 1967 - 1968. [Full Text] [PDF] |
||||
![]() |
C. I. Berul Congenital Long-QT Syndromes: Who's at Risk for Sudden Cardiac Death? Circulation, April 29, 2008; 117(17): 2178 - 2180. [Full Text] [PDF] |
||||
![]() |
I. Goldenberg, A. J. Moss, D. R. Peterson, S. McNitt, W. Zareba, M. L. Andrews, J. L. Robinson, E. H. Locati, M. J. Ackerman, J. Benhorin, et al. Risk Factors for Aborted Cardiac Arrest and Sudden Cardiac Death in Children With the Congenital Long-QT Syndrome Circulation, April 29, 2008; 117(17): 2184 - 2191. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goldenberg, A. J. Moss, J. Bradley, S. Polonsky, D. R. Peterson, S. McNitt, W. Zareba, M. L. Andrews, J. L. Robinson, M. J. Ackerman, et al. Long-QT Syndrome After Age 40 Circulation, April 29, 2008; 117(17): 2192 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Role of spatial dispersion of repolarization in inherited and acquired sudden cardiac death syndromes Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2024 - H2038. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes Europace, September 1, 2007; 9(suppl_4): iv4 - iv15. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. L. Vetter Clues or Miscues?: How to Make the Right Interpretation and Correctly Diagnose Long-QT Syndrome Circulation, May 22, 2007; 115(20): 2595 - 2598. [Full Text] [PDF] |
||||
![]() |
A. J. Moss, W. Shimizu, A. A.M. Wilde, J. A. Towbin, W. Zareba, J. L. Robinson, M. Qi, G. M. Vincent, M. J. Ackerman, E. S. Kaufman, et al. Clinical Aspects of Type-1 Long-QT Syndrome by Location, Coding Type, and Biophysical Function of Mutations Involving the KCNQ1 Gene Circulation, May 15, 2007; 115(19): 2481 - 2489. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Seth, A. J. Moss, S. McNitt, W. Zareba, M. L. Andrews, M. Qi, J. L. Robinson, I. Goldenberg, M. J. Ackerman, J. Benhorin, et al. Long QT Syndrome and Pregnancy J. Am. Coll. Cardiol., March 13, 2007; 49(10): 1092 - 1098. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Imboden, H. Swan, I. Denjoy, I. M. Van Langen, P. J. Latinen-Forsblom, C. Napolitano, V. Fressart, G. Breithardt, M. Berthet, S. Priori, et al. Female Predominance and Transmission Distortion in the Long-QT Syndrome N. Engl. J. Med., December 28, 2006; 355(26): 2744 - 2751. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Saarel Sudden Death and Long-QT Syndrome AAP Grand Rounds, December 1, 2006; 16(6): 62 - 63. [Full Text] [PDF] |
||||
![]() |
J. B. Hobbs, D. R. Peterson, A. J. Moss, S. McNitt, W. Zareba, I. Goldenberg, M. Qi, J. L. Robinson, A. J. Sauer, M. J. Ackerman, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA, September 13, 2006; 296(10): 1249 - 1254. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Goldenberg, J. Mathew, A. J. Moss, S. McNitt, D. R. Peterson, W. Zareba, J. Benhorin, L. Zhang, G. M. Vincent, M. L. Andrews, et al. Corrected QT Variability in Serial Electrocardiograms in Long QT Syndrome: The Importance of the Maximum Corrected QT for Risk Stratification J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1047 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. T. Locati QT Interval Duration Remains a Major Risk Factor in Long QT Syndrome Patients J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1053 - 1055. [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death--Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): 1064 - 1108. [Full Text] [PDF] |
||||
![]() |
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF] |
||||
![]() |
D. P. Zipes, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur. Heart J., September 1, 2006; 27(17): 2099 - 2140. [Full Text] [PDF] |
||||
![]() |
G. Monnig, L. Eckardt, H. Wedekind, W. Haverkamp, J. Gerss, P. Milberg, K. Wasmer, P. Kirchhof, G. Assmann, G. Breithardt, et al. Electrocardiographic risk stratification in families with congenital long QT syndrome Eur. Heart J., September 1, 2006; 27(17): 2074 - 2080. [Abstract] [Full Text] [PDF] |
||||
![]() |
Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF] |
||||
![]() |
L Eckardt, G Breithardt, and P Kirchhof Approach to wide complex tachycardias in patients without structural heart disease. Heart, May 1, 2006; 92(5): 704 - 711. [Full Text] [PDF] |
||||
![]() |
D. A. Cesario and G. W. Dec Implantable Cardioverter- Defibrillator Therapy in Clinical Practice J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1507 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. C. Stecker, C. Vickers, J. Waltz, C. Socoteanu, B. T. John, R. Mariani, J. H. McAnulty, K. Gunson, J. Jui, and S. S. Chugh Population-Based Analysis of Sudden Cardiac Death With and Without Left Ventricular Systolic Dysfunction: Two-Year Findings from the Oregon Sudden Unexpected Death Study J. Am. Coll. Cardiol., March 21, 2006; 47(6): 1161 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Abdelmawla and A. J. Mitchell Sudden cardiac death and antipsychotics. Part 1: Risk factors and mechanisms Advan. Psychiatr. Treat., January 1, 2006; 12(1): 35 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-X. Bai, J. Kurokawa, M. Tamagawa, H. Nakaya, and T. Furukawa Nontranscriptional Regulation of Cardiac Repolarization Currents by Testosterone Circulation, September 20, 2005; 112(12): 1701 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss and P. J. Schwartz 25th Anniversary of the International Long-QT Syndrome Registry: An Ongoing Quest to Uncover the Secrets of Long-QT Syndrome Circulation, March 8, 2005; 111(9): 1199 - 1201. [Full Text] [PDF] |
||||
![]() |
T. Aiba, W. Shimizu, M. Inagaki, T. Noda, S. Miyoshi, W.-G. Ding, D. P. Zankov, F. Toyoda, H. Matsuura, M. Horie, et al. Cellular and ionic mechanism for drug-induced long QT syndrome and effectiveness of verapamil J. Am. Coll. Cardiol., January 18, 2005; 45(2): 300 - 307. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Cardiac repolarization. The long and short of it Europace, January 1, 2005; 7(s2): S3 - S9. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noda, W. Shimizu, K. Satomi, K. Suyama, T. Kurita, N. Aihara, and S. Kamakura Classification and mechanism of Torsade de Pointes initiation in patients with congenital long QT syndrome Eur. Heart J., December 1, 2004; 25(23): 2149 - 2154. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Choi, L. J. Kopplin, D. J. Tester, M. L. Will, C. M. Haglund, and M. J. Ackerman Spectrum and Frequency of Cardiac Channel Defects in Swimming-Triggered Arrhythmia Syndromes Circulation, October 12, 2004; 110(15): 2119 - 2124. [Abstract] [Full Text] [PDF] |
||||
![]() |
Task Force Members, J. Lopez-Sendo, K. Swedberg, J. McMurray, J. Tamargo, A. P. Maggioni, H. Dargie, M. Tendera, F. Waagstein, J. Kjekshus, et al. Expert consensus document on {beta}-adrenergic receptor blockers: The Task Force on Beta-Blockers of the European Society of Cardiology Eur. Heart J., August 1, 2004; 25(15): 1341 - 1362. [Full Text] [PDF] |
||||
![]() |
K. Ueda, K. Nakamura, T. Hayashi, N. Inagaki, M. Takahashi, T. Arimura, H. Morita, Y. Higashiuesato, Y. Hirano, M. Yasunami, et al. Functional Characterization of a Trafficking-defective HCN4 Mutation, D553N, Associated with Cardiac Arrhythmia J. Biol. Chem., June 25, 2004; 279(26): 27194 - 27198. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P. Lee, L. Yeoh, N. D. Harris, C. M. Davies, R. T. Robinson, A. Leathard, C. Newman, I. A. Macdonald, and S. R. Heller Influence of Autonomic Neuropathy on QTc Interval Lengthening During Hypoglycemia in Type 1 Diabetes Diabetes, June 1, 2004; 53(6): 1535 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montanez, J. N. Ruskin, P. R. Hebert, G. A. Lamas, and C. H. Hennekens Prolonged QTc Interval and Risks of Total and Cardiovascular Mortality and Sudden Death in the General Population: A Review and Qualitative Overview of the Prospective Cohort Studies Arch Intern Med, May 10, 2004; 164(9): 943 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chugh, O. Senashova, A. Watts, P. T. Tran, Z. Zhou, Q. Gong, J. L. Titus, and S. J. Hayflick Postmortem molecular screening in unexplained sudden death J. Am. Coll. Cardiol., May 5, 2004; 43(9): 1625 - 1629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Mazzadi, X. Andre-Fouet, J. Duisit, V. Gebuhrer, N. Costes, P. Chevalier, C. Rodriguez, J.-J. Schott, H. Le Marec, P. Guicheney, et al. Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1286 - H1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zareba, A. J. Moss, E. H. Locati, M. H. Lehmann, D. R. Peterson, W. J. Hall, P. J. Schwartz, G. M. Vincent, S. G. Priori, J. Benhorin, et al. Modulating effects of age and gender on the clinical course of long QT syndrome by genotype J. Am. Coll. Cardiol., July 2, 2003; 42(1): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, P. J. Schwartz, C. Napolitano, R. Bloise, E. Ronchetti, M. Grillo, A. Vicentini, C. Spazzolini, J. Nastoli, G. Bottelli, et al. Risk Stratification in the Long-QT Syndrome N. Engl. J. Med., May 8, 2003; 348(19): 1866 - 1874. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss Long QT Syndrome JAMA, April 23, 2003; 289(16): 2041 - 2044. [Full Text] [PDF] |
||||
![]() |
S. M. Al-Khatib, N. M. A. LaPointe, J. M. Kramer, and R. M. Califf What Clinicians Should Know About the QT Interval JAMA, April 23, 2003; 289(16): 2120 - 2127. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V Pham Gender differences in cardiac development: are hormones at the heart of the matter? Cardiovasc Res, March 1, 2003; 57(3): 591 - 593. [Full Text] [PDF] |
||||
![]() |
W. Shimizu, T. Noda, H. Takaki, T. Kurita, N. Nagaya, K. Satomi, K. Suyama, N. Aihara, S. Kamakura, K. Sunagawa, et al. Epinephrine unmasks latent mutation carriers with LQT1 form of congenital long-QT syndrome J. Am. Coll. Cardiol., February 19, 2003; 41(4): 633 - 642. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Takenaka, T. Ai, W. Shimizu, A. Kobori, T. Ninomiya, H. Otani, T. Kubota, H. Takaki, S. Kamakura, and M. Horie Exercise Stress Test Amplifies Genotype-Phenotype Correlation in the LQT1 and LQT2 Forms of the Long-QT Syndrome Circulation, February 18, 2003; 107(6): 838 - 844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nemec, J. B. Hejlik, W.-K. Shen, and M. J. Ackerman Catecholamine-Induced T-Wave Lability in Congenital Long QT Syndrome: A Novel Phenomenon Associated With Syncope and Cardiac Arrest Mayo Clin. Proc., January 1, 2003; 78(1): 40 - 50. [Abstract] [PDF] |
||||
![]() |
C. Chiello Tracy, C. Cabo, J. Coromilas, J. Kurokawa, R. S. Kass, and A. L. Wit Electrophysiological consequences of human IKs channel expression in adult murine heart Am J Physiol Heart Circ Physiol, January 1, 2003; 284(1): H168 - H175. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H.T. Wehrens, M. A. Vos, P. A. Doevendans, and H. J.J. Wellens Novel Insights in the Congenital Long QT Syndrome Ann Intern Med, December 17, 2002; 137(12): 981 - 992. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Viitasalo, L. Oikarinen, H. Swan, H. Vaananen, K. Glatter, P. J. Laitinen, K. Kontula, H. V. Barron, L. Toivonen, and M. M. Scheinman Ambulatory Electrocardiographic Evidence of Transmural Dispersion of Repolarization in Patients With Long-QT Syndrome Type 1 and 2 Circulation, November 5, 2002; 106(19): 2473 - 2478. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Antzelevitch Sympathetic modulation of the long QT syndrome Eur. Heart J., August 2, 2002; 23(16): 1246 - 1252. [PDF] |
||||
![]() |
X Jouven, A Hagege, P Charron, L Carrier, O Dubourg, J M Langlard, S Aliaga, J B Bouhour, K Schwartz, M Desnos, et al. Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy Heart, August 1, 2002; 88(2): 153 - 157. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Noda, H. Takaki, T. Kurita, K. Suyama, N. Nagaya, A. Taguchi, N. Aihara, S. Kamakura, K. Sunagawa, K. Nakamura, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome Eur. Heart J., June 2, 2002; 23(12): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hayashi, M. Shimizu, H. Ino, M. Yamaguchi, H. Mabuchi, N. Hoshi, and H. Higashida Characterization of a novel missense mutation E637K in the pore-S6 loop of HERG in a patient with long QT syndrome Cardiovasc Res, April 1, 2002; 54(1): 67 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. V. Pham and M. R. Rosen Sex, hormones, and repolarization Cardiovasc Res, February 15, 2002; 53(3): 740 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E Conrath, A. A.M Wilde, R. J.E Jongbloed, M. Alders, I. M van Langen, J Peter van Tintelen, P. A Doevendans, and T. Opthof Gender differences in the long QT syndrome: effects of {beta}-adrenoceptor blockade Cardiovasc Res, February 15, 2002; 53(3): 770 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, J. A. Camm, R. Cappato, S. M. Cobbe, C. Di Mario, et al. TASK FORCE ON SUDDEN CARDIAC DEATH, EUROPEAN SOCIETY OF CARDIOLOGY: Summary of Recommendations Europace, January 1, 2002; 4(1): 3 - 18. [Abstract] [PDF] |
||||
![]() |
C. Antzelevitch Heterogeneity of cellular repolarization in LQTS: the role of M cells Eur. Heart J. Suppl., September 1, 2001; 3(suppl_K): K2 - K16. [Abstract] [PDF] |
||||
![]() |
S.G. Priori, E. Aliot, C. Blomstrom-Lundqvist, L. Bossaert, G. Breithardt, P. Brugada, A.J. Camm, R. Cappato, S.M. Cobbe, C. Di Mario, et al. Task Force on Sudden Cardiac Death of the European Society of Cardiology Eur. Heart J., August 2, 2001; 22(16): 1374 - 1450. [PDF] |
||||
![]() |
H. Hemingway, M. Malik, and M. Marmot Social and psychosocial influences on sudden cardiac death, ventricular arrhythmia and cardiac autonomic function Eur. Heart J., July 1, 2001; 22(13): 1082 - 1101. [PDF] |
||||
![]() |
Y. Tanabe, M. Inagaki, T. Kurita, N. Nagaya, A. Taguchi, K. Suyama, N. Aihara, S. Kamakura, K. Sunagawa, K. Nakamura, et al. Sympathetic stimulation produces a greater increase in both transmural and spatial dispersion of repolarization in LQT1 than LQT2 forms of congenital long QT syndrome J. Am. Coll. Cardiol., March 1, 2001; 37(3): 911 - 919. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Piippo, H. Swan, M. Pasternack, H. Chapman, K. Paavonen, M. Viitasalo, L. Toivonen, and K. Kontula A founder mutation of the potassium channel KCNQ1 in long QT syndrome: Implications for estimation of disease prevalence and molecular diagnostics J. Am. Coll. Cardiol., February 1, 2001; 37(2): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, R. Bloise, and L. Crotti The long QT syndrome Europace, January 1, 2001; 3(1): 16 - 27. [PDF] |
||||
![]() |
A. Benatar, A. Feenstra, T. Decraene, and Y. Vandenplas Effects of Cisapride on Corrected QT Interval, Heart Rate, and Rhythm in Infants Undergoing Polysomnography Pediatrics, December 1, 2000; 106(6): 85e - 85. [Abstract] [Full Text] |
||||
![]() |
R. S. Kass and C. Cabo Channel structure and drug-induced cardiac arrhythmias PNAS, October 24, 2000; 97(22): 11683 - 11684. [Full Text] [PDF] |
||||
![]() |
I. Splawski, J. Shen, K. W. Timothy, M. H. Lehmann, S. Priori, J. L. Robinson, A. J. Moss, P. J. Schwartz, J. A. Towbin, G. M. Vincent, et al. Spectrum of Mutations in Long-QT Syndrome Genes : KVLQT1, HERG, SCN5A, KCNE1, and KCNE2 Circulation, September 5, 2000; 102(10): 1178 - 1185. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Abriel, X. H. T. Wehrens, J. Benhorin, B. Kerem, and R. S. Kass Molecular Pharmacology of the Sodium Channel Mutation D1790G Linked to the Long-QT Syndrome Circulation, August 22, 2000; 102(8): 921 - 925. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu and C. Antzelevitch Effects of a K+ Channel Opener to Reduce Transmural Dispersion of Repolarization and Prevent Torsade de Pointes in LQT1, LQT2, and LQT3 Models of the Long-QT Syndrome Circulation, August 8, 2000; 102(6): 706 - 712. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. H. T. Wehrens, H. Abriel, C. Cabo, J. Benhorin, and R. S. Kass Arrhythmogenic Mechanism of an LQT-3 Mutation of the Human Heart Na+ Channel {alpha}-Subunit : A Computational Analysis Circulation, August 1, 2000; 102(5): 584 - 590. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Benhorin, R. Taub, M. Goldmit, B. Kerem, R. S. Kass, I. Windman, and A. Medina Effects of Flecainide in Patients With New SCN5A Mutation : Mutation-Specific Therapy for Long-QT Syndrome? Circulation, April 11, 2000; 101(14): 1698 - 1706. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu and C. Antzelevitch Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome J. Am. Coll. Cardiol., March 1, 2000; 35(3): 778 - 786. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Pond, B. K. Scheve, A. T. Benedict, K. Petrecca, D. R. Van Wagoner, A. Shrier, and J. M. Nerbonne Expression of Distinct ERG Proteins in Rat, Mouse, and Human Heart. RELATION TO FUNCTIONAL IKr CHANNELS J. Biol. Chem., February 25, 2000; 275(8): 5997 - 6006. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Moss, W. Zareba, W. J. Hall, P. J. Schwartz, R. S. Crampton, J. Benhorin, G. M. Vincent, E. H. Locati, S. G. Priori, C. Napolitano, et al. Effectiveness and Limitations of {beta}-Blocker Therapy in Congenital Long-QT Syndrome Circulation, February 15, 2000; 101(6): 616 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Dorostkar, M. Eldar, B. Belhassen, and M. M. Scheinman Long-Term Follow-Up of Patients With Long-QT Syndrome Treated With {beta}-Blockers and Continuous Pacing Circulation, December 14, 1999; 100(24): 2431 - 2436. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ackerman, D. J. Tester, C.-b. J. Porter, and W. D. Edwards Molecular Diagnosis of the Inherited Long-QT Syndrome in a Woman Who Died after Near-Drowning N. Engl. J. Med., October 7, 1999; 341(15): 1121 - 1125. [Full Text] [PDF] |
||||
![]() |
Gene-specific lethality of arrhythmic events in the long QT syndrome? A message from the International Registry Eur. Heart J., August 2, 1999; 20(16): 1137 - 1139. [PDF] |
||||
![]() |
X. Jouven, M. Desnos, C. Guerot, and P. Ducimetiere Predicting Sudden Death in the Population : The Paris Prospective Study I Circulation, April 20, 1999; 99(15): 1978 - 1983. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen, D. Zhang, R. L. Gingell, A. J. Moss, C. Napolitano, S. G. Priori, P. J. Schwartz, E. Kehoe, J. L. Robinson, E. Schulze-Bahr, et al. Homozygous Deletion in KVLQT1 Associated With Jervell and Lange-Nielsen Syndrome Circulation, March 16, 1999; 99(10): 1344 - 1347. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.C. de Bruyne, A.W. Hoes, J.A. Kors, A. Hofman, J.H. van Bemmel, and D.E. Grobbee Prolonged QT interval predicts cardiac and all-cause mortality in the elderly: The Rotterdam Study Eur. Heart J., February 2, 1999; 20(4): 278 - 284. [Abstract] [PDF] |
||||
![]() |
S. G. Priori, C. Napolitano, and P. J. Schwartz Low Penetrance in the Long-QT Syndrome : Clinical Impact Circulation, February 2, 1999; 99(4): 529 - 533. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu and C. Antzelevitch Cellular Basis for the ECG Features of the LQT1 Form of the Long-QT Syndrome : Effects of ß-Adrenergic Agonists and Antagonists and Sodium Channel Blockers on Transmural Dispersion of Repolarization and Torsade de Pointes Circulation, November 24, 1998; 98(21): 2314 - 2322. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF] |
||||
![]() |
W. Zareba, A. J. Moss, P. J. Schwartz, G. M. Vincent, J. L. Robinson, S. G. Priori, J. Benhorin, E. H. Locati, J. A. Towbin, M. T. Keating, et al. Influence of the Genotype on the Clinical Course of the Long-QT Syndrome N. Engl. J. Med., October 1, 1998; 339(14): 960 - 965. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhou, Q. Gong, M. L. Epstein, and C. T. January HERG Channel Dysfunction in Human Long QT Syndrome. INTRACELLULAR TRANSPORT AND FUNCTIONAL DEFECTS J. Biol. Chem., August 14, 1998; 273(33): 21061 - 21066. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Swan, K. Saarinen, K. Kontula, L. Toivonen, and M. Viitasalo Evaluation of QT interval duration and dispersion and proposed clinical criteria in diagnosis of long QT syndrome in patients with a genetically uniform type of LQT1 J. Am. Coll. Cardiol., August 1, 1998; 32(2): 486 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. An, X. L. Wang, B. Kerem, J. Benhorin, A. Medina, M. Goldmit, and R. S. Kass Novel LQT-3 Mutation Affects Na+ Channel Activity Through Interactions Between {alpha}- and ß1-Subunits Circ. Res., July 27, 1998; 83(2): 141 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Marsh, M. H. Lehmann, R. H. Ritchie, J. K. Gwathmey, G. E. Green, and R. J. Schiebinger Androgen Receptors Mediate Hypertrophy in Cardiac Myocytes Circulation, July 21, 1998; 98(3): 256 - 261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Priori, P. J. Schwartz, C. Napolitano, L. Bianchi, A. Dennis, M. D. Fusco, A. M. Brown, and G. Casari A Recessive Variant of the Romano-Ward Long-QT Syndrome? Circulation, June 23, 1998; 97(24): 2420 - 2425. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. H. Locati, W. Zareba, A. J. Moss, P. J. Schwartz, G. M. Vincent, M. H. Lehmann, J. A. Towbin, S. G. Priori, C. Napolitano, J. L. Robinson, et al. Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT Syndrome : Findings From the International LQTS Registry Circulation, June 9, 1998; 97(22): 2237 - 2244. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Shimizu, T. Kurita, K. Matsuo, K. Suyama, N. Aihara, S. Kamakura, J. A. Towbin, and K. Shimomura Improvement of Repolarization Abnormalities by a K+ Channel Opener in the LQT1 Form of Congenital Long-QT Syndrome Circulation, April 28, 1998; 97(16): 1581 - 1588. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Li, Q. Chen, A. J. Moss, J. Robinson, V. Goytia, J. C. Perry, G. M. Vincent, S. G. Priori, M. H. Lehmann, S. W. Denfield, et al. New Mutations in the KVLQT1 Potassium Channel That Cause Long-QT Syndrome Circulation, April 7, 1998; 97(13): 1264 - 1269. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1991 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |